Cancer Therapeutics Biotherapeutic Market Trends: Bi-Specific Antibodies and Next-Generation Platforms.
Bi-Specific Antibodies: Targeting Two Pathways Simultaneously Bi-specific antibodies (BsAbs) are an exciting advancement in biotherapeutic design, engineered to bind to two distinct antigens simultaneously. This dual-targeting capability offers several clinical advantages, including enhanced efficacy by blocking two key cancer pathways or by bringing an immune cell (like a T-cell) directly into...
0 Комментарии 0 Поделились 2 Просмотры 0 предпросмотр
Lifesone https://lifesone.com